XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -17.50%2.42B | -17.50%2.42B | -11.03%2.95B | -37.19%2.41B | -39.58%2.72B | -50.48%2.93B | -50.48%2.93B | -37.37%3.32B | -33.55%3.84B | 65.69%4.51B |
-Cash and cash equivalents | -17.50%2.42B | -17.50%2.42B | -11.03%2.95B | -37.19%2.41B | -39.58%2.72B | -50.48%2.93B | -50.48%2.93B | -37.37%3.32B | -33.55%3.84B | 65.69%4.51B |
Receivables | 24.13%1.33B | 24.13%1.33B | 21.12%1.18B | 46.92%1.22B | 34.56%1.02B | 15.72%1.07B | 15.72%1.07B | 3.07%971.99M | -7.55%833.47M | -8.83%755.03M |
-Accounts receivable | 15.31%1.07B | 15.31%1.07B | 18.78%964.74M | 44.45%1.02B | 22.72%924.06M | 9.03%929.14M | 9.03%929.14M | 14.46%812.19M | 5.24%703.97M | 26.88%752.97M |
-Taxes receivable | 82.06%257.51M | 82.06%257.51M | 33.02%212.58M | 60.31%207.6M | 4,358.03%91.88M | 93.72%141.44M | 93.72%141.44M | -31.56%159.81M | -44.33%129.5M | -99.12%2.06M |
Inventory | -0.79%140.56M | -0.79%140.56M | 6.61%144.84M | 12.97%147.86M | 14.47%147.36M | 12.38%141.68M | 12.38%141.68M | 19.89%135.86M | 13.72%130.89M | 26.15%128.73M |
Other current assets | -37.89%478.58M | -37.89%478.58M | -32.97%559.7M | -23.07%622.58M | -18.27%688.22M | 32.13%770.5M | 32.13%770.5M | 105.36%834.96M | 139.64%809.27M | 130.34%842.03M |
Total current assets | -11.14%4.36B | -11.14%4.36B | -8.11%4.83B | -21.50%4.41B | -26.60%4.57B | -39.78%4.91B | -39.78%4.91B | -40.12%5.26B | -38.72%5.62B | 38.01%6.23B |
Non current assets | ||||||||||
Net PPE | 0.85%29.73B | 0.85%29.73B | 0.69%29.61B | -0.03%29.5B | -0.04%29.53B | -0.93%29.48B | -0.93%29.48B | -1.14%29.41B | -0.98%29.51B | 15.48%29.54B |
-Gross PPE | -14.21%29.73B | -14.21%29.73B | 0.69%29.61B | -0.03%29.5B | -0.04%29.53B | -0.04%34.65B | -0.04%34.65B | -14.88%29.41B | -14.34%29.51B | 15.48%29.54B |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -5.37%-5.18B | -5.37%-5.18B | ---- | ---- | ---- |
Goodwill and other intangible assets | -0.43%6.86B | -0.43%6.86B | 1.11%6.95B | 0.72%6.81B | 0.86%6.84B | 4.71%6.89B | 4.71%6.89B | -11.29%6.88B | -18.55%6.76B | -3.55%6.78B |
-Goodwill | -0.40%5.15B | -0.40%5.15B | 0.64%5.18B | 2.47%5.15B | 2.55%5.15B | 2.71%5.17B | 2.71%5.17B | 4.00%5.14B | 6.87%5.03B | 44.61%5.02B |
-Other intangible assets | -0.53%1.72B | -0.53%1.72B | 2.49%1.78B | -4.36%1.66B | -3.98%1.69B | 11.17%1.72B | 11.17%1.72B | -38.23%1.73B | -51.81%1.73B | -50.61%1.76B |
Investments and advances | 58.07%380.63M | 58.07%380.63M | 78.52%414.16M | 51.49%237.82M | 60.00%246.17M | 39.16%240.8M | 39.16%240.8M | 24.89%232M | 0.90%156.99M | -84.74%153.86M |
Non current deferred assets | --39.59M | --39.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non current assets | 1.07%858.98M | 1.07%858.98M | 16.98%933.4M | -0.31%855.77M | 6.83%888.97M | -17.41%849.87M | -17.41%849.87M | -7.72%797.9M | -14.54%858.46M | 62.02%832.17M |
Total non current assets | 1.09%37.87B | 1.09%37.87B | 1.60%37.91B | 0.32%37.41B | 0.52%37.51B | -0.21%37.46B | -0.21%37.46B | -3.20%37.31B | -5.03%37.29B | 9.30%37.31B |
Total assets | -0.32%42.23B | -0.32%42.23B | 0.40%42.74B | -2.54%41.82B | -3.36%42.08B | -7.27%42.37B | -7.27%42.37B | -10.05%42.57B | -11.41%42.91B | 12.66%43.54B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -51.60%412.66M | -51.60%412.66M | -5.07%391.84M | 12.02%401.92M | 8.42%448.16M | 46.60%852.61M | 46.60%852.61M | -2.72%412.76M | -5.65%358.81M | 36.90%413.34M |
-accounts payable | -10.62%412.66M | -10.62%412.66M | -5.07%391.84M | 12.02%401.92M | 29.02%448.16M | 24.85%461.72M | 24.85%461.72M | 2.23%412.76M | -0.13%358.81M | 23.51%347.34M |
-Total tax payable | ---- | ---- | ---- | ---- | ---- | 84.59%390.89M | 84.59%390.89M | ---- | ---- | --65.99M |
Current accrued expenses | 81.08%2.94B | 81.08%2.94B | 10.62%2.82B | 10.31%2.6B | 7.99%2.59B | 18.53%1.62B | 18.53%1.62B | 17.71%2.55B | 20.37%2.36B | 16.94%2.39B |
Current debt and capital lease obligation | ---- | ---- | --675M | ---- | ---- | -94.04%84.15M | -94.04%84.15M | ---- | -97.18%35.2M | -97.08%36.49M |
-Current debt | ---- | ---- | --675M | ---- | ---- | ---- | ---- | ---- | -97.18%35.2M | -97.08%36.49M |
-Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | -33.42%84.15M | -33.42%84.15M | ---- | ---- | ---- |
Current deferred liabilities | ---- | ---- | ---- | ---- | ---- | -7.51%566.22M | -7.51%566.22M | ---- | ---- | ---- |
Current liabilities | 7.22%3.35B | 7.22%3.35B | 31.22%3.89B | 9.12%3B | 6.66%3.03B | -30.78%3.13B | -30.78%3.13B | -49.76%2.96B | -50.41%2.75B | -20.98%2.84B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -0.10%31.44B | -0.10%31.44B | -0.97%31.33B | -1.28%31.4B | -1.88%31.39B | -3.41%31.47B | -3.41%31.47B | -2.23%31.63B | -1.34%31.81B | 43.33%31.99B |
-Long term debt | 0.29%6.36B | 0.29%6.36B | -4.17%6.23B | -5.71%6.29B | -8.36%6.27B | -14.65%6.34B | -14.65%6.34B | -9.77%6.51B | -6.09%6.67B | -34.89%6.84B |
-Long term capital lease obligation | -0.20%25.08B | -0.20%25.08B | -0.15%25.09B | -0.10%25.11B | -0.12%25.12B | -0.09%25.13B | -0.09%25.13B | -0.06%25.13B | 0.00%25.14B | 112.91%25.15B |
Non current deferred liabilities | -1.72%2.81B | -1.72%2.81B | -6.62%2.79B | -6.96%2.8B | -5.29%2.85B | -3.65%2.86B | -3.65%2.86B | 5.03%2.99B | 0.78%3.01B | 23.18%3.01B |
Other non current liabilities | 67.69%910.09M | 67.69%910.09M | 68.23%880.3M | 55.47%768M | 59.47%750.28M | 111.76%542.71M | 111.76%542.71M | 93.12%523.28M | 54.18%494M | 67.99%470.5M |
Total non current liabilities | 0.82%35.16B | 0.82%35.16B | -0.42%35B | -0.97%34.97B | -1.35%34.99B | -2.61%34.87B | -2.61%34.87B | -0.91%35.15B | -0.66%35.31B | 41.64%35.47B |
Total liabilities | 1.34%38.51B | 1.34%38.51B | 2.03%38.89B | -0.24%37.97B | -0.76%38.02B | -5.76%38B | -5.76%38B | -7.87%38.11B | -7.38%38.06B | 33.77%38.31B |
Shareholders'equity | ||||||||||
Share capital | -9.86%2.94M | -9.86%2.94M | -12.91%2.97M | -13.55%3.05M | -14.24%3.15M | -13.85%3.27M | -13.85%3.27M | -12.32%3.41M | -11.45%3.53M | -14.72%3.67M |
-common stock | -9.86%2.94M | -9.86%2.94M | -12.91%2.97M | -13.55%3.05M | -14.24%3.15M | -13.85%3.27M | -13.85%3.27M | -12.32%3.41M | -11.45%3.53M | -14.72%3.67M |
Retained earnings | -15.89%3.08B | -15.89%3.08B | -23.35%3.04B | -27.62%3.17B | -29.28%3.39B | -23.57%3.66B | -23.57%3.66B | -18.65%3.96B | -23.74%4.38B | 11.05%4.8B |
Paid-in capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Gains losses not affecting retained earnings | -142.54%-61.22M | -142.54%-61.22M | 31,149.43%191.58M | 24.37%37.38M | 62.49%59.81M | 329.55%143.9M | 329.55%143.9M | 98.18%-617K | 277.41%30.06M | 267.26%36.81M |
Total stockholders'equity | -20.67%3.02B | -20.67%3.02B | -18.50%3.23B | -27.25%3.21B | -28.57%3.46B | -21.12%3.81B | -21.12%3.81B | -18.09%3.97B | -22.98%4.42B | -4.46%4.84B |
Noncontrolling interests | 25.19%696.48M | 25.19%696.48M | 25.59%622.94M | 47.73%633.64M | 53.73%602.79M | 3.61%556.33M | 3.61%556.33M | -55.72%496M | -73.31%428.91M | -92.07%392.1M |
Total equity | -14.83%3.72B | -14.83%3.72B | -13.60%3.85B | -20.61%3.85B | -22.41%4.06B | -18.65%4.37B | -18.65%4.37B | -25.16%4.46B | -34.00%4.85B | -47.74%5.23B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |